A potentially toxic drug interaction between pethidine (meperidine) and phenobarbitone

Lancet. 1977 Feb 19;1(8008):398-9. doi: 10.1016/s0140-6736(77)92606-x.

Abstract

The concomitant administration of pethidine (meperidine) and phenobarbitone results in enhanced sedation in a patient previously tolerant of pethidine. A complete analysis of pethidine kinetics and metabolism was performed in this patient, in four additional patients undergoing similar treatment but not receiving phenobarbitone, and in a volunteer after placebo and phentobarbitone pretreatment. The results indicate that phentobarbitone enhances the production of the toxic metabolite norpethidine by increasing N-demethylation.

Publication types

  • Case Reports
  • Clinical Trial
  • Controlled Clinical Trial

MeSH terms

  • Adult
  • Brain Neoplasms / surgery
  • Drug Synergism
  • Drug Therapy, Combination
  • Female
  • Half-Life
  • Humans
  • Meperidine / metabolism
  • Meperidine / therapeutic use
  • Meperidine / toxicity*
  • Neuroblastoma / surgery
  • Pain, Postoperative / prevention & control
  • Phenobarbital / pharmacology*
  • Phenobarbital / therapeutic use
  • Pregnancy
  • Pregnancy Complications / surgery
  • Preoperative Care

Substances

  • Meperidine
  • Phenobarbital